Eldrin Foster Lewis, MD

Offices

2 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

17 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lewis’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

17 of 17 plans

Sort by

Plans whose provider directory lists this clinician

Alignment Health BreathEasy (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Clarity (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Harmony (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Honor+ Plan (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health My Choice CalCare (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Silicon (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health smartHMO (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health the ONE (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
SCAN Balance (HMO C-SNP)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN Classic (HMO)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN MyChoice (HMO)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN Strive (HMO C-SNP)	SCAN Health Plan	Listed	Oct 3, 2026
DualConnect (HMO D-SNP)	Santa Clara Family Health Plan	Listed	Sep 1, 2026

California Medical Board record

Licence C169157 · Current

Licensed to practise in California · since 2020 · expires 2028-06-30 · University of Pennsylvania School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

American Board of Internal Medicine - Advanced Heart Failure and Transplant
American Board of Internal Medicine - Cardiovascular Disease

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Stanford Health Care

Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	5.31 (4.24 to 6.37) · 8,661 cases	Worse	Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	14.1 (12.7 to 15.7) · 2,191 cases	Worse	Jan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths	4.08 (1.95 to 6.21) · 5,296 cases	Better	Jul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.317	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.446	Better	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.241	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.7 (0.6 to 0.9) · 3,348 cases	Better	Jan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.06 (0.45 to 1.67) · 5,374 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.86 (0.72 to 1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	166.09 (137.88 to 194.3) · 470 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.1 · 192 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	6.4 · 146 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	9.7 · 253 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	6.3 · 880 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.3 · 935 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	8.7 · 501 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.1 · 7,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.13 (0 to 0.27) · 20,799 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.28 (0.14 to 0.43) · 23,182 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	0.94 (0.2 to 1.68) · 5,694 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.36 (1.54 to 3.19) · 7,846 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.2 (3.76 to 6.64) · 5,603 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.38 (0.23 to 2.53) · 2,211 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.52 (0.21 to 0.83) · 19,915 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.6 · 416 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.869	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.857	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.368	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	16.2 · 247 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	20.5 · 1,021 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	47.8 · 258 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-1.6 · 990 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	20.8 · 976 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.5 · 959 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.2 (4.4 to 6.2) · 2,191 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.1 · 425 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	9.6 · 158 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	19.6 · 183 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.7 (10.4 to 15.4) · 4,578 cases	No different	Jan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Sort by

Patient survey stars by topic at Stanford Health Care

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at Stanford Health Care

Room was "always" clean	75%
Nurses "always" communicated well	82%
Doctors "always" communicated well	81%
Staff "always" explained	63%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	89%
Doctors "always" explained things so they could understand	76%
Doctors "always" listened carefully	80%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	79%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	53%
"YES", patients would definitely recommend the hospital	83%
Staff "always" explained possible side effects	50%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$38,181

Medicare paid this office $38,181 for 330 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Critical care, first 30-74 minutes	15	$8,675	$185
Long return visit (40+ min)	48	$6,285	$119
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	19	$4,774	$106
Return visit (30+ min)	43	$3,672	$83
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	16	$2,469	$71

See all 10 services

Sort by

Every Original Medicare service billed

Critical care, first 30-74 minutes	15	$8,675	$185
Long return visit (40+ min)	48	$6,285	$119
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	19	$4,774	$106
Return visit (30+ min)	43	$3,672	$83
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	16	$2,469	$71
Long return visit (40+ min)	11	$1,766	$161
Short return visit (20+ min)	27	$1,604	$55
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	144	$1,121	$7
Short return visit (20+ min)	11	$1,059	$88
Heart rhythm review and interpretation of continous external ekg over 8-15 days	11	$250	$23

Who their Medicare patients are

330 Original Medicare patients in 2024. Average age 72 · Under 65 16% · 85 and older 15% · Women 48% · Also on Medicaid 33% · Health risk score 2.52. Sicker patients than 9 in 10 peers; the typical cardiology clinician is at 1.71.

Conditions among them: High blood pressure 75% · Heart failure 65% · Chronic kidney disease 53% · Coronary heart disease 51% · Atrial fibrillation 46% · Diabetes 45% · COPD 21% · Depression 21% · Cancer 19% · Stroke 19% · Dementia 18%.

The office billed $198,026, Medicare allowed $50,185 and paid $38,181; for 528 services of 25 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	330	528	72	2.52	$198,026	$38,181
2023	248	522	74	3.45	$134,505	$36,275
2022	162	409	71	3.05	$133,266	$30,934
2021	104	238	68	3.58	$60,645	$19,243
2020	147	379	70	3.27	$100,152	$21,952
2019	967	1,924	72	2.60	$289,630	$62,500
2018	936	1,781	71	2.48	$236,496	$50,763
2017	857	1,815	71	2.60	$273,739	$59,293
2016	795	1,626	71	2.45	$257,961	$54,765
2015	794	1,677	71	2.38	$242,138	$52,837
2014	701	1,505	70	2.17	$204,322	$45,666
2013	591	1,417	69	2.51	$196,245	$41,822

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 8 services

Sort by

Original Medicare services billed in 2023

Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	33	$8,361	$107
Long return visit (40+ min)	50	$7,537	$130
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	37	$7,387	$71
Return visit (30+ min)	34	$3,914	$85
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	16	$1,986	$117
Short return visit (20+ min)	15	$954	$56
Hospital discharge day management, 30 minutes or less	11	$816	$74
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	94	$797	$7

2022: 8 services

Sort by

Original Medicare services billed in 2022

Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	33	$7,519	$63
Return visit (30+ min)	47	$4,756	$86
Long return visit (40+ min)	26	$3,753	$125
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	23	$3,315	$92
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	18	$2,044	$114
Short return visit (20+ min)	20	$1,224	$51
Hospital discharge day management, 30 minutes or less	17	$1,065	$63
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	20	$164	$7

2021: 5 services

Sort by

Original Medicare services billed in 2021

Return visit (30+ min)	52	$5,485	$87
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	14	$3,941	$66
Long return visit (40+ min)	25	$3,215	$115
New patient visit (60+ min)	18	$2,739	$152
Short return visit (20+ min)	19	$1,330	$58

2020: 7 services

Sort by

Original Medicare services billed in 2020

Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	34	$8,757	$65
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	18	$2,924	$94
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	14	$1,732	$124
Hospital discharge day management, 30 minutes or less	20	$1,323	$66
Return visit (30+ min)	19	$1,322	$70
Short return visit (20+ min)	19	$562	$30
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	84	$440	$5

2019: 10 services

Sort by

Original Medicare services billed in 2019

Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	106	$26,216	$63
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	861	$7,426	$7
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	33	$6,045	$90
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	32	$4,266	$118
Short return visit (20+ min)	77	$3,903	$41
Evaluation of lower heart chamber assist device	20	$3,657	$40
Long return visit (40+ min)	37	$3,598	$90
Hospital discharge day management, 30 minutes or less	45	$2,944	$64
Return visit (30+ min)	29	$1,985	$66
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	17	$118	$7

2018: 11 services

Sort by

Original Medicare services billed in 2018

Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	67	$17,092	$61
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	857	$7,462	$7
Short return visit (20+ min)	84	$4,994	$41
Long return visit (40+ min)	49	$4,892	$91
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	27	$3,118	$111
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	21	$3,096	$86
Return visit (30+ min)	37	$2,673	$62
Evaluation of lower heart chamber assist device	16	$2,351	$40
Hospital discharge day management, 30 minutes or less	22	$1,709	$63
New patient visit (60+ min)	12	$1,604	$134
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	13	$80	$6

2017: 10 services

Sort by

Original Medicare services billed in 2017

Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	91	$25,055	$61
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	758	$6,435	$7
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	40	$4,662	$111
Short return visit (20+ min)	81	$4,603	$39
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	25	$4,559	$88
Evaluation of lower heart chamber assist device	23	$4,004	$39
Hospital discharge day management, 30 minutes or less	42	$2,892	$62
Long return visit (40+ min)	24	$2,822	$91
Return visit (30+ min)	29	$1,867	$58
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	12	$85	$7

2016: 10 services

Sort by

Original Medicare services billed in 2016

Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	93	$18,898	$59
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	28	$5,886	$85
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	681	$5,256	$7
Short return visit (20+ min)	84	$4,707	$38
Evaluation of lower heart chamber assist device	27	$4,412	$38
Long return visit (40+ min)	32	$3,593	$88
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	32	$3,587	$109
Return visit (30+ min)	42	$2,810	$57
Hospital discharge day management, 30 minutes or less	28	$1,683	$60
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	11	$63	$6

2015: 10 services

Sort by

Original Medicare services billed in 2015

Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	85	$19,624	$59
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	703	$5,811	$7
Short return visit (20+ min)	91	$5,072	$37
Evaluation of lower heart chamber assist device	23	$4,498	$38
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	21	$3,777	$86
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	29	$3,377	$113
Hospital discharge day management, 30 minutes or less	40	$2,488	$59
Return visit (30+ min)	34	$2,328	$57
New patient visit (60+ min)	16	$2,215	$138
Long return visit (40+ min)	17	$1,557	$92

2014: 8 services

Sort by

Original Medicare services billed in 2014

Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	64	$14,832	$59
Short return visit (20+ min)	102	$6,329	$39
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	626	$5,390	$7
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	20	$4,942	$85
Evaluation of lower heart chamber assist device	25	$3,805	$37
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	18	$2,029	$113
Return visit (30+ min)	26	$1,726	$60
Hospital discharge day management, 30 minutes or less	24	$1,560	$60

2013: 10 services

Sort by

Original Medicare services billed in 2013

Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	84	$17,472	$56
Short return visit (20+ min)	100	$6,003	$36
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	509	$4,599	$6
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	20	$2,238	$83
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	22	$2,131	$93
Hospital discharge day management, 30 minutes or less	31	$1,793	$58
Return visit (30+ min)	23	$1,391	$56
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes	20	$1,317	$31
Long return visit (40+ min)	14	$1,275	$85
Evaluation of lower heart chamber assist device	14	$1,108	$34

Medicaid work

$737 in 2024

Medicaid paid $737 for 87 billed services this clinician did in 2024, up to 60 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2024

Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	87	$737

Sort by

Medicaid work by year

2024	87	1	60	$737
2023	146	2	92	$1,650
2022	52	1	12	$1,958
2020	32	1	31	$91
2019	611	2	62	$3,535
2018	702	2	67	$4,875

See the largest Medicaid services in earlier years

2023

Sort by

Largest Medicaid services in 2023

Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	114	$977
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES	32	$673

2022

Sort by

Largest Medicaid services in 2022

SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES	52	$1,958

2020

Sort by

Largest Medicaid services in 2020

Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	32	$91

2019

Sort by

Largest Medicaid services in 2019

Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	548	$1,863
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES	63	$1,672

2018

Sort by

Largest Medicaid services in 2018

SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES	113	$3,081
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	589	$1,794

Drugs they prescribed that Part D paid

$257,622

Pharmacies billed $257,622 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 1,020) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.

751 generic and fewer than 11 brand-name prescriptions · $257,622 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Entresto	61	$83,519	$1,369
Jardiance	95	$77,230	$813
Eliquis	27	$32,538	$1,205
Digoxin	22	$4,635	$211
Mycophenolic Acid	22	$3,717	$169

See all 25 drugs

Sort by

Every Part D drug this clinician prescribed

Entresto	61	$83,519	$1,369
Jardiance	95	$77,230	$813
Eliquis	27	$32,538	$1,205
Digoxin	22	$4,635	$211
Mycophenolic Acid	22	$3,717	$169
Humalog Kwikpen U-100	12	$1,875	$156
Icosapent Ethyl	13	$1,791	$138
Mycophenolate Mofetil	19	$1,469	$77
Rosuvastatin	88	$1,159	$13
Bumetanide	23	$1,077	$47
Tacrolimus	13	$864	$66
Losartan	76	$732	$10
Metoprolol	45	$634	$14
Spironolactone	61	$483	$8
Carvedilol	48	$441	$9
Midodrine	12	$426	$36
Atorvastatin	44	$297	$7
Pravastatin	18	$222	$12
Levothyroxine	15	$159	$11
Lisinopril	22	$130	$6
Hydralazine	17	$103	$6
Famotidine	11	$94	$9
Amlodipine Besylate	29	$85	$3
Gabapentin	14	$71	$5
Furosemide	13	$64	$5

Year by year

Sort by

Part D prescribing by year

2024	1,020	139	0% (0)	None	$257,622
2023	806	143	0% (0)	None	$148,190
2022	770	106	0% (0)	12%	$118,629
2021	690	96	0% (0)	19%	$101,744
2020	350	73	0% (0)	26%	$82,710
2019	716	101	0% (0)	22%	$111,763
2018	752	93	None	24%	$81,020
2017	703	85	0% (0)	27%	$67,225
2016	676	85	0% (0)	25%	$55,110
2015	613	72	None	27%	$47,982
2014	600	63	0% (0)	22%	$36,701
2013	407	54	0% (0)	22%	$20,537

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 26 drugs

Sort by

Part D drugs prescribed in 2023

Entresto	32	$46,538	$1,454
Eliquis	11	$18,136	$1,649
Jardiance	13	$12,751	$981
Tacrolimus	31	$6,967	$225
Digoxin	18	$4,024	$224
Mycophenolate Mofetil	26	$3,225	$124
Rosuvastatin	59	$1,427	$24
Bumetanide	20	$1,088	$54
Metoprolol	46	$919	$20
Potassium Chloride	15	$507	$34
Losartan	47	$484	$10
Atorvastatin	45	$444	$10
Carvedilol	33	$369	$11
Pantoprazole	15	$360	$24
Isosorbide Mononitrate Er	14	$325	$23
Spironolactone	26	$318	$12
Amlodipine Besylate	37	$272	$7
Lisinopril	26	$259	$10
Levothyroxine	16	$239	$15
Furosemide	21	$218	$10
Clopidogrel	14	$202	$14
Pravastatin	15	$129	$9
Gabapentin	19	$97	$5
Minoxidil	12	$80	$7
Famotidine	12	$54	$4
Allopurinol	11	$34	$3

2022: 25 drugs

Sort by

Part D drugs prescribed in 2022

Entresto	27	$36,348	$1,346
Tacrolimus	59	$3,082	$52
Rosuvastatin	60	$1,765	$29
Ezetimibe	16	$1,471	$92
Bumetanide	24	$1,167	$49
Metoprolol	29	$814	$28
Mycophenolate Mofetil	16	$686	$43
Atorvastatin	57	$476	$8
Carvedilol	30	$372	$12
Prednisone	25	$286	$11
Spironolactone	24	$278	$12
Losartan	30	$270	$9
Potassium Chloride	21	$249	$12
Pravastatin	12	$212	$18
Hydralazine	15	$186	$12
Lisinopril	23	$157	$7
Levothyroxine	11	$128	$12
Finasteride	13	$122	$9
Tamsulosin	12	$115	$10
Benazepril	11	$111	$10
Furosemide	17	$99	$6
Amlodipine Besylate	24	$96	$4
Isosorbide Mononitrate Er	16	$86	$5
Famotidine	16	$63	$4
Sulfamethoxazole-Trimethoprim	14	$53	$4

2021: 22 drugs

Sort by

Part D drugs prescribed in 2021

Entresto	38	$31,430	$827
Zortress	16	$27,169	$1,698
Sirolimus	18	$6,220	$346
Tacrolimus	47	$2,695	$57
Bumetanide	26	$1,950	$75
Mycophenolate Mofetil	19	$922	$49
Hydralazine	19	$474	$25
Rosuvastatin	33	$459	$14
Ezetimibe	12	$419	$35
Metoprolol	21	$407	$19
Furosemide	50	$371	$7
Potassium Chloride	20	$319	$16
Losartan	13	$210	$16
Famotidine	13	$207	$16
Carvedilol	34	$194	$6
Prednisone	22	$186	$8
Atorvastatin	24	$168	$7
Spironolactone	18	$164	$9
Pravastatin	12	$155	$13
Sulfamethoxazole-Trimethoprim	17	$153	$9
Amlodipine Besylate	20	$87	$4
Lisinopril	17	$42	$2

2020: 8 drugs

Sort by

Part D drugs prescribed in 2020

Entresto	46	$45,167	$982
Metoprolol	40	$1,105	$28
Potassium Chloride	11	$548	$50
Atorvastatin	20	$354	$18
Isosorbide Mononitrate Er	12	$322	$27
Carvedilol	19	$232	$12
Lisinopril	27	$179	$7
Furosemide	16	$162	$10

2019: 19 drugs

Sort by

Part D drugs prescribed in 2019

Entresto	48	$48,691	$1,014
Eliquis	18	$11,369	$632
Pradaxa	11	$11,017	$1,002
Metoprolol	69	$2,606	$38
Potassium Chloride	31	$1,529	$49
Torsemide	25	$980	$39
Losartan	28	$801	$29
Atorvastatin	38	$606	$16
Isosorbide Mononitrate Er	29	$568	$20
Klor-Con M20	13	$475	$37
Carvedilol	25	$463	$19
Furosemide	38	$406	$11
Amiodarone	15	$328	$22
Lisinopril	44	$296	$7
Levothyroxine	15	$141	$9
Spironolactone	14	$125	$9
Omeprazole	11	$123	$11
Allopurinol	12	$112	$9
Atenolol	11	$81	$7

2018: 21 drugs

Sort by

Part D drugs prescribed in 2018

Entresto	44	$32,526	$739
Metoprolol	70	$2,967	$42
Torsemide	46	$1,854	$40
Atorvastatin	39	$791	$20
Klor-Con M20	33	$774	$23
Fenofibrate	12	$684	$57
Potassium Chloride	14	$638	$46
Isosorbide Mononitrate Er	24	$497	$21
Amiodarone	14	$451	$32
Carvedilol	33	$422	$13
Digoxin	11	$413	$38
Lisinopril	56	$394	$7
Hydralazine	15	$277	$18
Atenolol	15	$276	$18
Furosemide	41	$272	$7
Omeprazole	17	$268	$16
Allopurinol	15	$242	$16
Spironolactone	23	$218	$9
Losartan	24	$172	$7
Levothyroxine	16	$70	$4
Amlodipine Besylate	11	$56	$5

2017: 24 drugs

Sort by

Part D drugs prescribed in 2017

Entresto	60	$28,098	$468
Pradaxa	17	$8,774	$516
Eplerenone	14	$2,930	$209
Metoprolol	75	$2,807	$37
Torsemide	22	$1,476	$67
Klor-Con 10	11	$1,397	$127
Atorvastatin	36	$709	$20
Valsartan	15	$689	$46
Potassium Chloride	14	$675	$48
Isosorbide Mononitrate Er	25	$619	$25
Amiodarone	22	$469	$21
Klor-Con M20	13	$436	$34
Carvedilol	42	$308	$7
Pravastatin	11	$304	$28
Lisinopril	43	$300	$7
Warfarin	11	$280	$25
Furosemide	38	$242	$6
Spironolactone	29	$239	$8
Allopurinol	15	$203	$14
Hydralazine	15	$186	$12
Levothyroxine	12	$180	$15
Losartan	18	$105	$6
Simvastatin	12	$28	$2
Amlodipine Besylate	11	$18	$2

2016: 22 drugs

Sort by

Part D drugs prescribed in 2016

Entresto	36	$16,364	$455
Metoprolol	54	$3,131	$58
Eplerenone	19	$2,329	$123
Rosuvastatin	11	$2,115	$192
Isosorbide Mononitrate Er	29	$1,217	$42
Tacrolimus	11	$1,002	$91
Digoxin	13	$794	$61
Torsemide	18	$781	$43
Valsartan	13	$593	$46
Atorvastatin	37	$584	$16
Potassium Chloride	15	$560	$37
Pravastatin	21	$542	$26
Carvedilol	54	$264	$5
Furosemide	42	$216	$5
Spironolactone	22	$210	$10
Amiodarone	13	$208	$16
Lisinopril	38	$195	$5
Diltiazem 24hr Er	11	$163	$15
Losartan	23	$120	$5
Amlodipine Besylate	14	$82	$6
Atenolol	11	$63	$6
Simvastatin	15	$31	$2

2015: 17 drugs

Sort by

Part D drugs prescribed in 2015

Ranexa	14	$5,969	$426
Isosorbide Mononitrate Er	81	$3,605	$45
Metoprolol	46	$3,136	$68
Eplerenone	27	$3,028	$112
Klor-Con 10	14	$1,734	$124
Atorvastatin	31	$1,051	$34
Torsemide	25	$1,026	$41
Potassium Chloride	18	$780	$43
Valsartan	14	$767	$55
Lisinopril	38	$263	$7
Furosemide	54	$234	$4
Amiodarone	13	$179	$14
Losartan	29	$171	$6
Carvedilol	18	$127	$7
Amlodipine Besylate	14	$101	$7
Spironolactone	20	$85	$4
Metoprolol	15	$50	$3

2014: 16 drugs

Sort by

Part D drugs prescribed in 2014

Metoprolol	59	$4,568	$77
Diovan	16	$3,345	$209
Klor-Con 10	14	$1,746	$125
Atorvastatin	27	$1,736	$64
Torsemide	39	$1,634	$42
Isosorbide Mononitrate Er	74	$1,157	$16
Eplerenone	16	$932	$58
Digoxin	14	$896	$64
Amiodarone	20	$439	$22
Hydralazine	20	$307	$15
Lisinopril	29	$215	$7
Atenolol	20	$165	$8
Carvedilol	11	$136	$12
Furosemide	36	$131	$4
Spironolactone	22	$131	$6
Metoprolol	14	$45	$3

2013: 10 drugs

Sort by

Part D drugs prescribed in 2013

Metoprolol	31	$3,236	$104
Atorvastatin	21	$1,735	$83
Klor-Con 10	15	$1,222	$81
Isosorbide Mononitrate Er	42	$808	$19
Hydralazine	21	$351	$17
Lisinopril	37	$321	$9
Carvedilol	24	$269	$11
Furosemide	26	$215	$8
Simvastatin	21	$162	$8
Metoprolol	14	$75	$5

Money from drug and device companies

$30,449 in 2025

Sort by

Industry payments by year

2025	3	11	$30,341	$30,449
2024	4	19	$3,806	$14,689
2023	3	9	$4,250	$4,710
2022	1	1	$1,180	$1,180
2021	1	1	$1,050	$1,050
2020	2	2	$5,200	$5,200

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

AstraZeneca UK	None	$27,184	5 payments Consulting · 2025-12-24 · $537 Consulting · 2025-12-22 · $19,064 Consulting · 2025-12-08 · $537 Consulting · 2025-09-24 · $6,981 Meals · 2025-03-28 · $65
AstraZeneca Pharmaceuticals LP	Farxiga	$3,222	5 payments Consulting for Farxiga · 2025-12-11 · $537 Consulting for Farxiga · 2025-12-11 · $537 Consulting for Farxiga · 2025-12-10 · $537 Consulting · 2025-07-22 · $537 Consulting for Farxiga · 2025-07-09 · $1,074
CVRx	Barostim Neo System	$43	1 payment Meals for Barostim Neo System · 2025-07-14 · $43

See all 11 published payments

Sort by

Every published payment

AstraZeneca UK	Consulting · 2025-12-24	None	$537
AstraZeneca UK	Consulting · 2025-12-22	None	$19,064
AstraZeneca Pharmaceuticals LP	Consulting · 2025-12-11	Farxiga	$537
AstraZeneca Pharmaceuticals LP	Consulting · 2025-12-11	Farxiga	$537
AstraZeneca Pharmaceuticals LP	Consulting · 2025-12-10	Farxiga	$537
AstraZeneca UK	Consulting · 2025-12-08	None	$537
AstraZeneca UK	Consulting · 2025-09-24	None	$6,981
AstraZeneca Pharmaceuticals LP	Consulting · 2025-07-22	None	$537
CVRx	Meals · 2025-07-14	Barostim Neo System	$43
AstraZeneca Pharmaceuticals LP	Consulting · 2025-07-09	Farxiga	$1,074
AstraZeneca UK	Meals · 2025-03-28	None	$65

See earlier years (2024, 2023, 2022, 2021, 2020)

2024: $14,689

Sort by

Payments by company in 2024

AstraZeneca UK	None	$10,592	12 payments Meals · 2024-08-30 · $39 Meals · 2024-05-09 · $14 Travel · 2024-05-09 · $118 Travel · 2024-05-09 · $70 Meals · 2024-05-09 · $14 Travel · 2024-05-09 · $184 Meals · 2024-05-09 · $44 Meals · 2024-05-09 · $14 Meals · 2024-05-09 · $51 Travel · 2024-05-09 · $9,813 Meals · 2024-05-09 · $46 Travel · 2024-05-09 · $184
Merck Sharp & Dohme	Verquvo	$3,142	5 payments Consulting for Verquvo · 2024-12-11 · $1,000 Meals for Verquvo · 2024-11-15 · $126 Consulting for Verquvo · 2024-10-02 · $1,000 Meals for Verquvo · 2024-08-29 · $16 Consulting for Verquvo · 2024-08-05 · $1,000
AstraZeneca Pharmaceuticals LP	None	$806	1 payment Consulting · 2024-11-11 · $806
Philips North America	(Ck4) Mcot	$150	1 payment Meals for (Ck4) Mcot · 2024-05-07 · $150

2023: $4,710

Sort by

Payments by company in 2023

Merck Sharp & Dohme	Verquvo	$4,370	6 payments Consulting for Verquvo · 2023-11-29 · $1,250 Meals for Verquvo · 2023-11-10 · $73 Meals for Verquvo · 2023-11-10 · $22 Consulting for Verquvo · 2023-09-27 · $1,500 Consulting for Verquvo · 2023-07-19 · $1,500 Meals for Verquvo · 2023-03-03 · $25
Impulse Dynamics (USA)	Optimizer	$178	1 payment Meals for Optimizer · 2023-07-15 · $178
Novartis Pharmaceuticals	Leqvio	$162	2 payments Meals for Leqvio · 2023-06-30 · $88 Meals for Leqvio · 2023-06-29 · $74

2022: $1,180

Sort by

Payments by company in 2022

Akebia Therapeutics	None	$1,180	1 payment Consulting · 2022-05-11 · $1,180

2021: $1,050

Sort by

Payments by company in 2021

Medtronic	None	$1,050	1 payment Consulting · 2021-03-11 · $1,050

2020: $5,200

Sort by

Payments by company in 2020

Merck Sharp & Dohme	None	$3,000	1 payment Consulting · 2020-05-18 · $3,000
Amgen	Corlanor	$2,200	1 payment Consulting for Corlanor · 2020-08-26 · $2,200

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Sort by

Research payments by company and study

AstraZeneca Pharmaceuticals LP · Pt010 Pearl Triple Mdi Phase 3 Exacerbation Ethos Pt010005 · 2020	Their institution	$283,388
Novartis Pharmaceuticals Corporation · Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor Arni Versus Ace Inhibitor Trial To Determine Impact on Serious Events After Myocardial Infarction Paradise Mi · 2020	Their institution	$269,083
Novartis Pharmaceuticals Corporation · Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor Arni Versus Ace Inhibitor Trial To Determine Impact on Serious Events After Myocardial Infarction Paradise Mi · 2019	Their institution	$243,929
Novartis Pharmaceuticals Corporation · Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor Arni Versus Ace Inhibitor Trial To Determine Impact on Serious Events After Myocardial Infarction Paradise Mi · 2021	Their institution	$222,044
AKEBIA THERAPEUTICS INC · Akb-6548-Ci-0014 · 2022	Their institution	$205,203
AKEBIA THERAPEUTICS INC · Akb-6548-Ci-0015 · 2022	Their institution	$160,159
Novartis Pharmaceuticals Corporation · Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor Arni Versus Ace Inhibitor Trial To Determine Impact on Serious Events After Myocardial Infarction Paradise Mi · 2023	Their institution	$145,302
AKEBIA THERAPEUTICS INC · Akb-6548-Ci-0017 · 2022	Their institution	$80,136
Amgen Inc. · Aranesp Start Ckd · 2019	Their institution	$55,009
AKEBIA THERAPEUTICS INC · Akb-6548-Ci-0016 · 2022	Their institution	$51,505

Professional record

NPI: 1144287442
Licence: CA C169157California C169157: Current · expires 2028-06-30
Group: Stanford Health Care
Video visits: Lists video visits
Gender: Male

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 207RA0001X (207RA0001X); Cardiology (207RC0000X)
Mailing address: 300 Pasteur Dr, Stanford, CA, 94305
NPI first listed: 2006-04-28
NPI last updated: 2024-04-23
NPI record certified: 2024-04-23

This is when the NPI record was last certified, not a medical board exam.